Acquiring Company
ARMADA ACQUISITION CORP. III
Acquired Company
Brains Bioceutical
United States
VancouverArtificial IntelligenceManufacturingBiotechnologyPharmaceuticalDescription
Armada Acquisition Corp. III and Brains Bioceutical Corp. have entered into a definitive business combination agreement, announced November 5, 2026. Upon completion, the combined company is expected to operate as Brains Therapeutics Corp. and trade on Nasdaq under the ticker BAPI. The transaction is intended to establish Brains as a publicly traded cannabinoid life sciences enterprise.
Who to call at ARMADA ACQUISITION CORP. III, and when
When ARMADA ACQUISITION CORP. III changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ARMADA ACQUISITION CORP. III raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARMADA ACQUISITION CORP. III, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARMADA ACQUISITION CORP. III. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARMADA ACQUISITION CORP. III makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Brains Bioceutical?
Brains Bioceutical was acquired by ARMADA ACQUISITION CORP. III, based in United States. The deal was reported on November 5, 2026. Armada Acquisition Corp. ARMADA ACQUISITION CORP. III is privately held and operates in Artificial Intelligence.
When did ARMADA ACQUISITION CORP. III acquire Brains Bioceutical?
ARMADA ACQUISITION CORP. III's acquisition of Brains Bioceutical was reported on November 5, 2026. Armada Acquisition Corp. III and Brains Bioceutical Corp. have entered into a definitive business combination agreement, announced November 5, 2026. Upon completion, the combined company is expected to operate as Brains Therapeutics Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Brains Bioceutical do?
Brains Bioceutical Corp. is a global leader in natural GMP-compliant cannabinoid pharmaceuticals. It is privately held, operating in Manufacturing, and is based in Vancouver.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.